Table 1.
Demographic characteristics and clinical features | Patients | |
---|---|---|
Gender | F | 18 (43%) |
M | 24 (57%) | |
Age | Median (Min–Max) | 47.5 (20–74) |
Years of schooling | NI | 3 (7%) |
AA | 6 (14%) | |
< 4 years | 16 (38%) | |
4–7 years | 9 (21%) | |
> 7 years | 8 (19%) | |
Grade of disability | NI | 5 (12%) |
0 | 12 (29%) | |
1 | 17 (40%) | |
2 | 8 (19%) | |
Ridley and Jopling clinical classification scale | TT | 1 (2%) |
BT | 1 (2%) | |
BB | 5 (12%) | |
BL | 10 (24%) | |
LL | 19 (45%) | |
Indeterminate | 1 (2%) | |
Pure neuritic leprosy | 5 (12%) | |
WHO classification | PB | 7 (17%) |
MB | 35 (83%) | |
DN4 score | < 4/10 | 3/40 |
≥ 4/10 | 37/40 | |
Hamilton depression scale score | NI | 5 (12%) |
Absent | 8 (19%) | |
Mild | 16 (38%) | |
Moderate | 6 (14%) | |
Severe | 7 (17%) | |
Severity of pain | Mild | 0 |
Moderate | 17 (40%) | |
Severe | 25 (60%) | |
Relationship between onset of pain and the beginning of MDT | Before MDT | 19 (45%) |
During MDT | 8 (19%) | |
After MDT | 15 (36%) | |
Previous leprosy reaction | 32 (76%) |
AA = illiterate and literate; BB = mid-borderline; BL = borderline-lepromatous; BT = borderline-tuberculoid; DN4 = douleur neuropathique 4; F = female; LL = lepromatous; M = male; Max = maximum; MB = multibacillary; MDT = multidrug therapy; Min = minimum; NI = not informed; PB = paucibacillary; TT = tuberculoid.